Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis

J Yi, Z He, S Xu, S Feng - International Urology and Nephrology, 2019 - Springer
Background The optimal therapy for immunoglobulin A nephropathy (IgAN) remains
uncertain. Leflunomide (LEF) is an immunosuppressive drug which may reduce deposition …

Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine

M Kanbay, L Ozbek, M Guldan, S Copur, J Barratt - Journal of Nephrology, 2024 - Springer
IgA nephropathy is the commonest pattern of primary glomerular disease in the world, with
high rates of progression to kidney failure. As IgA nephropathy commonly causes kidney …

Shared genetic correlations between kidney diseases and sepsis

T Zhang, Y Cui, S Jiang, L Jiang, L Song… - Frontiers in …, 2024 - frontiersin.org
Background Clinical studies have indicated a comorbidity between sepsis and kidney
diseases. Individuals with specific mutations that predispose them to kidney conditions are …

Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis

D Zhang, B Xia, X Zhang, P Liang, X Hu - BMC urology, 2024 - Springer
Background and objective The effectiveness of immunosuppressive and corticosteroid
treatments for Immunoglobulin A (IgA) nephropathy (IgAN) remains thoroughly evaluated …

Comparative long-term renal allograft outcomes of recurrent immunoglobulin A with severe activity in kidney transplant recipients with and without rituximab: an …

W Chancharoenthana, A Leelahavanichkul… - Journal of Clinical …, 2021 - mdpi.com
Recurrent IgA nephropathy (IgAN) remains an important cause of allograft loss in renal
transplantation. Due to the limited efficacy of corticosteroid in the treatment of recurrent …

Two decades outcomes of posttransplant immunoglobulin A nephropathy in live donor renal transplantation

M Khurana, N Prasad, M Behera… - Indian Journal of …, 2022 - journals.lww.com
Background: The data on long-term outcomes of posttransplant immunoglobulin A
nephropathy (IgAN) are confounding and vary with geography and ethnicity worldwide. We …

Retracted: Long noncoding RNA Mirt2 prohibits lipopolysaccharide‐evoked HK‐2 cell injury via modulation of microRNA‐126

C Bai, N Nie, Y Li, C Zhang, M Xu, Z Li - Biofactors, 2020 - Wiley Online Library
Long noncoding RNA myocardial infarction‐associated transcript 2 (lncRNA Mirt2) is a
burgeoning lncRNA, its anti‐inflammatory capacity has been testified. Nonetheless, the …

Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.

A Duan, L Liu, Y Lou, D Zhang, H Li… - Clinical …, 2019 - search.ebscohost.com
Background: The current study aims to observe the correlation between the expression of
miR-152-5p in urine samples and the condition of IgA nephropathy (IgAN). Methods: From …

Recurrent Renal Disease After Transplantation

SS Balani, PR Brakeman - Pediatric Solid Organ Transplantation: A …, 2023 - Springer
In the pediatric population, primary glomerulonephritis diseases, including focal segmental
glomerulosclerosis (FSGS), IgA nephropathy (IgAN), and membranoproliferative GN …

[HTML][HTML] Color Doppler ultrasound and hemodynamics for evaluating graft dysfunction in recurrent immunoglobulin a nephropathy

J Zhang, GD Chen, J Qiu, Y Tan, GC Liu… - Annals of …, 2021 - ncbi.nlm.nih.gov
Color Doppler Ultrasound and Hemodynamics for Evaluating Graft Dysfunction in Recurrent
Immunoglobulin A Nephropathy - PMC Back to Top Skip to main content NIH NLM Logo …